imipramine has been researched along with phosphotyrosine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Damsky, C; Hwang, F; Phillips, PD; Ross, AH; Vance, P | 1 |
Bolen, J; DiFazio, L; Ginalis, E; Greco, R; Haimovich, B; Ji, P; Purohit, U; Regan, C; Rowley, RB | 1 |
2 other study(ies) available for imipramine and phosphotyrosine
Article | Year |
---|---|
Inhibition of epidermal growth factor-induced phosphorylation by trifluoperazine.
Topics: Animals; Antibodies, Monoclonal; Cell Division; Cell Line; Chlorpromazine; Electrophoresis, Polyacrylamide Gel; Epidermal Growth Factor; ErbB Receptors; Imipramine; Mice; Microscopy, Electron, Scanning; Phosphorylation; Phosphotyrosine; Receptors, Cell Surface; Sulfonamides; Trifluoperazine; Tyrosine | 1985 |
The FcgammaRII receptor triggers pp125FAK phosphorylation in platelets.
Topics: Antibodies, Monoclonal; Blood Platelets; Cell Adhesion Molecules; Chelating Agents; Cytoplasmic Granules; Egtazic Acid; Enzyme Inhibitors; Enzyme Precursors; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Imipramine; Immunoglobulin G; In Vitro Techniques; Indoles; Intracellular Signaling Peptides and Proteins; Maleimides; Phosphorylation; Phosphotyrosine; Platelet Adhesiveness; Platelet Aggregation; Protein-Tyrosine Kinases; Receptors, IgG; Serotonin; Syk Kinase; Thromboxane B2 | 1996 |